CROI 2017 Program and Information

Program and Agenda

1030 COST-EFFECTIVENESS OF DIFFERENT DELIVERY APPROACHES FOR HIV SELF-TESTING Valentina Cambiano 1 , Cheryl Johnson 2 , Carmen Figueroa 2 , Paul Revill 3 , Rachel Baggaley 2 , Elizabeth L. Corbett 4 , Tsitsi Apollo 5 , Karin Hatzold 6 , Frances Cowan 7 , Andrew Phillips 1 1 Univ Coll London, London, UK, 2 WHO, Geneva, Switzerland, 3 Univ of York, York, UK, 4 London Sch of Hygiene & Trop Med, London, UK, 5 Zimbabwe Ministry of Hlth and Child Care, Harare, Zimbabwe, 6 Pop Services Intl, Harare, Zimbabwe, 7 Cntr for Sexual Hlth and HIV/AIDS Rsr, Harare, Zimbabwe 1031 THE COST OF NOT RETESTING: HIVMISDIAGNOSIS IN THE ART “TEST-AND-OFFER”ERA Jeffrey Eaton 1 , Cheryl Johnson 2 , Simon Gregson 1 1 Imperial Coll London, London, UK, 2 WHO, Geneva, Switzerland 1032 MODELING THE COST-EFFECTIVENESS OF ASSISTED PARTNER NOTIFICATION FOR HIV IN KENYA Monisha Sharma 1 , Jennifer Smith 2 , Carey Farquhar 1 , Roger Ying 3 , Peter Cherutich 4 , Beatrice Wamuti 5 , Matthew R. Golden 1 , Felix Abuna 5 , Ruanne V. Barnabas 6 1 Univ of Washington, Seattle, WA, USA, 2 Imperial Coll London, London, UK, 3 Weill Cornell Med Coll, New York, NY, USA, 4 Ministry of Hlth, Nairobi, Kenya, 5 Kenyatta Natl Hosp, Nairobi, Kenya, 6 Univ of Washington, Seattle, USA 2:30 PM - 4:00 PM 1054 CHARACTERIZATION OFMORE THAN10,000 ZIKA VIRUS TEST RESULTS IN THE US Joseph M. Volpe 1 , Dajie Luo 1 , Arren Fisher 1 , Mindy Nye 2 , Barbara Body 2 , Marcia Eisenberg 1 1 LabCorp, Durham, NC, USA, 2 LabCorp, Burlington, NC, USA 1055LB ZIKA VIRUS PERSISTENCE IN BODY FLUIDS Gabriela Paz-Bailey 1 , Eli Rosenberg 2 , Katherine Doyle 1 , Jorge Munoz- Jordan 1 , Gilberto Santiago 1 , Liore Klein 3 , Janice Perez 1 , Stephen Waterman 1 , Luisa Alvarado 4 , Tyler Sharp 1 1 CDC, Atlanta, GA, USA, 2 Emory Univ, Atlanta, GA, USA, 3 Caduceus Healthcare Inc, Ponce, PR, USA, 4 Ponce Univ, Ponce, PR, USA 1056LB NEUROLOGIC CONSEQUENCES OF POSTNATAL ZIKA VIRUS INFECTION IN INFANTS Maud Mavigner 1 , Justin O’Neal 2 , Siddhartha Bhaumik 1 , Jakob Habib 1 , Cameron Robinson 1 , Maria Alvarado 3 , Xiaodong Zhang 3 , Jens Wrammert 1 , Mehul Suthar 2 , Ann Chahroudi 1 1 Emory Univ, Atlanta, GA, USA, 2 Emory Vaccine Center, Atlanta, GA, USA, 3 Yerkes Natl Primate Rsr Cntr, Atlanta, GA, USA 1057LB ZIKA VIRUS PROTECTION BY A SINGLE LOW-DOSE NUCLEOSIDE- MODIFIEDmRNA VACCINATION Michael J. Hogan 1 , Norbert Pardi 1 , Rebecca S. Pelc 2 , Hanne Anderson 3 , Charles McGee 4 , Michael J. Hope 5 , Mark G. Lewis 3 , Theodore C. Pierson 2 , Barton F. Haynes 4 , DrewWeissman 1 1 Univ of Pennsylvania, Philadelphia, PA, USA, 2 NIAID, Bethesda, MD, USA, 3 Bioqual, Inc, Rockville, MD, USA, 4 Duke Univ, Durham, NC, USA, 5 Acuitas Therapeutics, Vancouver, BC, Canada Poster P-Y1 EMERGING VIRUSES: ZIKA VIRUS Poster Hall - 4 EF

Poster Sessions • Tuesday

CROI 2017 121